From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells
- 5 June 2004
- Vol. 69 (6) , 401-418
- https://doi.org/10.1016/j.steroids.2004.03.014
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Differences in the form of the salt-transformed estrogen receptor when bound by estrogen versus antiestrogenThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Steroid antagonists Satellite workshop of the 8th International Congress of Endocrinology, Kyodai Kaikan, Kyoto, JapanFEBS Letters, 1989
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: Applicability and caveatsThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature, 1986
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983